Ledger.Open graph →

SEC Form D · Amendment · filed February 8, 2019

Good Therapeutics, Inc

Offering

$22.3M

Sold

$11.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Mitchell Mutz · Seattle, WADirector Karl Handelsman · Seattle, WADirector John Mckearn · Seattle, WADirector Nicholas Walrod · Seattle, WADirector John Mulligan · Seattle, WAExec · Director · Promoter Piotr Biezychudek · Broomfield, CODirector Eimear Cowhey · Dublin, XXDirector Biao He · Athens, GADirector Jixiang An · Athens, GADirector Todd Miller · Broomfield, COExec · Director · Promoter Vitaly N. Vorobeychik · New York, NYDirector Philip N. Vorobeychik · New York, NYDirector Kirk Brown · Vancouver, WADirector Craig Moody · Vancouver, WAExec · Director · Promoter Ammar A. Bandukwala · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗